**Author details**

Abdullah Almater1 \*, Abdulrahman Alfaleh1,2, Khalid Alshomar1 and Saleh AlMesfer3

1 Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

2 Department of Ophthalmology, College of Medicine, Jouf University, Sakaka, Saudi Arabia

3 Division of Pediatric Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia

\*Address all correspondence to: aim-93@hotmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**65**

*Retinoblastoma: Update on Current Management DOI: http://dx.doi.org/10.5772/intechopen.88624*

[1] Shields JA, Shields CL, Parsons HM. Differential diagnosis of retinoblastoma. hyperplastic vitreous occurring in the same patient. Ophthalmology.

[11] Shields CL, Schoenberg E, Kocher K, et al. Lesions simulating retinoblastoma (pseudo retinoblastoma) in 604 cases: Results based on age at presentation. Ophthalmology.

[12] Brierley JD, Gospodarowicz MK, Wittekind C, editors. Retinoblastoma. In: TNM Classification of Malignant Tumours. 8th ed. Oxford, UK: Wiley-

[13] Mallipatna A, Gallie BL, Chévez-Barrios P, et al. Retinoblastoma. In: Amin MB, Edge SB, Greene FL, editors. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.

[14] Ellsworth RM. The practical management of retinoblastoma. Transactions of the American Ophthalmological Society. 1969;

[15] Linn Murphree A. Intraocular retinoblastoma: The case for a new group classification. Ophthalmology

[16] Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction

[17] Shields JA, Shields CL. Management and prognosis of retinoblastoma. In: Intraocular Tumors. A Text and Atlas. Philadelphia: WB Saunders; 1992.

Retinoblastoma. In: Shields JA, Shields CL, editors. Atlas of Intraocular Tumors.

Clinics of North America.

success. Ophthalmology. 2006;**113**(12):2276-2280

[18] Shields JA, Shields CL.

2005;**18**(1):41-53

pp. 377-392

1981;**88**:1087-1089

2013;**120**:311-316

Blackwell; 2017

pp. 819-831

**67**:462-534

[2] Shields JA, Augsburger JJ. Current approaches to the diagnosis and

management of retinoblastoma. Survey of Ophthalmology. 1981;**25**:347-372

[3] Yoshizumi MO, Thomas JV, Smith TR. Glaucoma-inducing mechanisms in eyes with retinoblastoma. Archives of Ophthalmology. 1978;**96**:105-110

[4] Chintagumpala M, Chevez-Barrios P,

[5] Smith EV, Gragoudas ES, Kolodny NH, et al. Magnetic resonance imaging: An emerging technique for the diagnosis of ocular disorders. International Ophthalmology. 1990;**14**:119-124

Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: Review of current management. The Oncologist.

[6] Brenner D, Elliston C, Hall E, et al. Estimated risks of radiationinduced fatal cancer from pediatric CT. AJR. American Journal of Roentgenology. 2001;**176**:289-296

[7] Kuker W, Ramaekers V. Persistent hyperplastic primary vitreous:

MRI. Neuroradiology. 1999;**41**:520-522

AJR. American Journal of Roentgenology.

[9] Chang MM, McLean IW, Merritt JC. Coats' disease: A study of 62 histologically confirmed cases. Journal of Pediatric Ophthalmology and Strabismus.

[8] Kaste SC, Jenkins JJ 3rd, Meyer D, et al. Persistent hyperplastic primary vitreous of the eye: Imaging findings

with pathologic correlation.

[10] Morgan KS, McLean IW. Retinoblastoma and persistent

1994;**162**:437-440

1984;**21**:163-168

2007;**12**:1237-1246

Retina. 1991;**11**:232-243

**References**

*Retinoblastoma: Update on Current Management DOI: http://dx.doi.org/10.5772/intechopen.88624*
